First Light Asset Management »

Apogee Therapeutics shares owned by First Light Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $22M 285k 75.48

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Neogenomics Common Stocks (NEO)
Si-bone Common Stocks (SIBN)
Palvella Therapeutics Common Stocks (PVLA)
Centessa Pharmaceuticals Common Stocks (CNTA)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Atricure Common Stocks (ATRC)
Vera Therapeutics Common Stocks (VERA)
Disc Medicine Common Stocks (IRON)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Edgewise Therapeutics Common Stocks (EWTX)
Madrigal Pharmaceuticals Common Stocks (MDGL)
Twist Bioscience Corporation Common Stocks (TWST)
Simulations Plus Common Stocks (SLP)
Rhythm Pharmaceuticals Common Stocks (RYTM)

View all positions for First Light Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Alliancebernstein
Perceptive Advisors
Affinity Asset Advisors
Citadel Advisors
Jpmorgan Chase & Co

View all funds holding Apogee Therapeutics